How often does Foghorn Therapeutics move more than the options market prices?

0 of the last 8 reports moved at least as far as the implied move.

FHTXNasdaqPharmaceutical Preparations

Foghorn Therapeutics Inc. (FHTX) earnings date, market-implied expected move, and options open interest by expiry

2.11

−0.02 · −0.94%

post 2.11 0.00%

Closed16:00 ET

Open2.14Volume673,564Mkt cap$124.7MEPS-0.99

Day2.11 – 2.220%52-wk1.79 – 7.615%

FHTX

Foghorn Therapeutics Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

News

34dFHTX trading halt (T3) · resumed 07:30 ET

News

Next report

Last report

+14.14%

vs ±84.1% implied · ×0.17

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

8hMRK · customerMerck posts nine-month net loss of $510 million; Q3 net income $5,065 million
6dLLY · customerWe're raising our price target on Eli Lilly as the obesity-drug boom rolls on

News

Largest filed tie

13F top-10 QoQ

−0.34%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

102 managers

Top fund weight

0.01%

FHTX weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Foghorn Therapeutics (FHTX) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

0 of 8≥ implied

avg implied: ±54.6%
avg realized: ±10.3%

Mar 6 '25Mar 6 '25confirmed±51.7%▲+0.44%×0.01

May 14 '25May 14 '25confirmed±28.7%▼−5.08%×0.18

Aug 5 '25Aug 5 '25confirmed±26.8%▼−2.72%×0.10

Q3 FY25Nov 5 '25confirmed±85.0%▲+13.31%×0.16

Jan 12 '26Jan 12 '26confirmed±84.2%▲+23.64%×0.28

Q1 FY26Mar 11 '26confirmed±13.9%▼−12.92%×0.93

May 7 '26May 7 '26confirmed±62.5%▼−10.26%×0.16

Q2 FY26Aug 6 '26confirmed±84.1%▲+14.14%×0.17

quarterimplied−85%0+85%realized×

Q2 FY26±84.1%▲+14.14%×0.17

May '26±62.5%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

2.24OI · 3 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

5300%Nov 2015d2370%

7460%Dec 1843d1.285830%1.28

100%Mar 19134d0.024010%0.02

ExpiryPutsCallsP/C

Nov 2015d5300%2370%2.24

Dec 1843d7460%5830%1.28

Mar 19134d100%4010%0.02

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−44.74%as filednet margin · revenue +391.95% QoQ · +112.68% YoY

Revenue$16M+391.95%

Gross profit$16M100.00%+391.95%

Operating income−$9M−54.78%+59.19%

Pre-tax income−$7M+63.82%

Net income−$7M−44.74%+63.82%

Cost of revenue$0—

Operating expenses$25M+0.15%

Other income$2M−4.95%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

NFP ×1.45· ±5.9% vs ±4.1% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±5.9%6 of 10×1.45

FOMCrate decision±4.0%10 of 24×0.99

PPIproducer prices±2.9%4 of 11×0.70

CPIconsumer prices±2.8%5 of 11×0.69

GDPgross domestic product±2.8%5 of 20×0.68

PCEpersonal income & outlays±2.4%5 of 20×0.60

CPROFcorporate profits±2.3%4 of 12×0.57

Bar = avg |move| to ±6% · tick = ±4.1% avg day · ×base = |move| ÷ ±4.1% · min 6 releases

Earnings history

EPS -0.10 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.10	—
Q1 FY26	Mar 11 '26 · confirmed	-0.29	—
Q3 FY25	Nov 5 '25 · confirmed	-0.25	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod